About this trial
The goal of this study is to develop a virtual group intervention to address post-traumatic stress related to cancer in young adult cancer survivors (YACs, aged 18-39). The study team will do this by integrating evidence-guided treatments and expert clinician feedback (N=10) on the content, delivery, and structure of the intervention. Next, the study team will refine this intervention through a pilot trial with a group of YACs (N=80).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Currently aged between 18 - 39;
Currently receiving or having completed treatment for cancer at the Mass General Cancer Institute within the past 5 years;
Reporting a score denoting at least mild symptoms of PTSD on the Post-traumatic Stress Checklist 5 (PCL-5);
English-speaking;
Disqualifiers
Unable to provide verbal consent
Reporting active symptoms of psychosis that preclude safe participation.
Trial design
Single group
Treatments tested in this trial
Psychosocial Intervention for Cancer-Related Post-Traumatic Stress in Young Adults
BehavioralA new group-based virtual intervention to address post-traumatic stress related to cancer in YACs, integrating evidence-guided treatments from Cognitive Processing Therapy and Mind-Body Resiliency interventions.
Treatment groups
Trial outcomes
Primary outcomes
Intervention Feasibility: Percent of Identified Prospective Participants Who Enroll
Percent of eligible participants who were offered participation and who enroll in the study by completing consent and baseline assessment.
Intervention Feasibility: Proportion of Participants Completing the Program
Percent of enrolled participants who complete the program, defined as completing 6 out of 8 sessions.
Intervention Acceptability
Acceptability will be assessed by the Client Satisfaction Questionnaire (CSQ-8). The intervention study will be considered acceptable if ≥80% of participants rate it as acceptable (defined as a CSQ-8 score ≥20).
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Zeba Ahmad, Ph.D.
Lead sponsor
Massachusetts General Hospital
Sponsor institution
American Cancer Society, Inc.
Collaborator
This trial is not recruiting at the moment. You can still explore other options: